APA (7th ed.) Citation

JH, P., JC, L., S, S., C, J., H, L., HJ, P., & HS, K. (2026). A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells. MedComm, 7(3), e70630. https://doi.org/10.1002/mco2.70630

Chicago Style (17th ed.) Citation

JH, Park, Lee JC, Sharma S, Jiang C, Lee H, Park HJ, and Kim HS. "A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells." MedComm 7, no. 3 (2026): e70630. https://doi.org/10.1002/mco2.70630.

MLA (9th ed.) Citation

JH, Park, et al. "A Novel Peptide, HS1002, Enhances Antitumor Activity via Dual Targeting of the GnRH Receptor and Human Telomerase Reverse Transcriptase in Prostate Cancer Cells." MedComm, vol. 7, no. 3, 2026, p. e70630, https://doi.org/10.1002/mco2.70630.